• Friday, Jul 01, 2022
  • Last Update : 04:24 pm

Country gets $300m for first ever biotech investment

  • Published at 09:10 pm August 11th, 2020
Country gets $300m for first ever biotech investment
Top officials of Oryx Biotech Holdings, Summit Technopolis and Bangladesh Hi-Tech Park Authority (BHTPA) attend a tripartite agreement signing ceremony in the capital on Tuesday Courtesy

The plant will have the capacity of processing 1,200 tons of plasma annually at 20 plasma collection centres all over the country

The country is all set to receive $300 million in investment in biotechnology for the first time ever.

Oryx Biotech, a subsidiary of Oryx Biotech Holdings based in China, will finance the amount in building up its plasma fractionation plant at Summit Technopolis at Bangabandhu Hi-Tech Park in Gazipur.

To this end, Oryx Biotech on Tuesday inked a tripartite agreement with Summit Technopolis and Bangladesh Hi-Tech Park Authority (BHTPA) in Dhaka.

The plant will have the capacity of processing 1,200 tonnes of plasma annually at 20 plasma collection centres all over the country.

Minister of State for Power, Energy and Mineral Resources Nasrul Hamid, Minister of State for ICT Zunaid Ahmed Palak, Senior Secretary of ICT Division N M Zeaul Alam, Managing Director of Bangladesh Hi-Tech Park Authority Hosne Ara Begum and Founder Chairman of Summit Group Muhammed Aziz Khan were present, among others, at the signing ceremony.

The plant aims to produce plasma derivatives, also known as life saving therapeutics, and other related products.

Aziz Khan said, “We are pleased to activate the nation's first and largest biotech investment of about $300 million on 25 acres of land and building provided by Summit Technopolis at Gazipur.

“It is most gratifying that this milestone plasma fractionation project, which will open new horizons in Bangladesh’s development, is happening in this auspicious year of Bangabandhu’s birth centenary,” he said.

With a great need of plasma in the potential treatment of Covid-19, the move is a timely investment for Bangladesh’s healthcare research and service sectors, the investing company said, and hoped that about 2,000 graduates would be employed to produce therapeutics such as Albumin, Immunoglobulin, Coagulation factor VIII, etc.

Managing Director of Oryx Biotech David Bo David Bo and his colleagues from China took part in the program virtually.

Facebook 50
blogger sharing button blogger
buffer sharing button buffer
diaspora sharing button diaspora
digg sharing button digg
douban sharing button douban
email sharing button email
evernote sharing button evernote
flipboard sharing button flipboard
pocket sharing button getpocket
github sharing button github
gmail sharing button gmail
googlebookmarks sharing button googlebookmarks
hackernews sharing button hackernews
instapaper sharing button instapaper
line sharing button line
linkedin sharing button linkedin
livejournal sharing button livejournal
mailru sharing button mailru
medium sharing button medium
meneame sharing button meneame
messenger sharing button messenger
odnoklassniki sharing button odnoklassniki
pinterest sharing button pinterest
print sharing button print
qzone sharing button qzone
reddit sharing button reddit
refind sharing button refind
renren sharing button renren
skype sharing button skype
snapchat sharing button snapchat
surfingbird sharing button surfingbird
telegram sharing button telegram
tumblr sharing button tumblr
twitter sharing button twitter
vk sharing button vk
wechat sharing button wechat
weibo sharing button weibo
whatsapp sharing button whatsapp
wordpress sharing button wordpress
xing sharing button xing
yahoomail sharing button yahoomail